PP_1170x120_10-25-21

potassium chloride extended-release tablets

Aurobindo gets FDA approval for potassium chloride extended release tablets

Aurobindo gets FDA approval for potassium chloride extended release tablets

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application potassium chloride extended-release tablets USP, 10 mEq, 15 mEq, and 20 mEq. Aurobindo Pharma’s potassium chloride extended release tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), potassium chloride extended

Glenmark generic of K-Dur approved

Glenmark generic of K-Dur approved

MUMBAI, India — Glenmark Pharmaceuticals Inc. USA has received final Food and Drug Administration approval for potassium chloride extended-release tablets. Glenmark said Wednesday that its potassium chloride ER tablets, which come in dosages of 10 mEq (750 mg) and 20 mEq (1500 mg), are a generic version of K-Dur ER tablets from Merck Sharp and

Adheris Health